Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01383941 · ClinicalTrials.gov registry record

Asthma Phenotypes in the Inner City

A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

Completed
Registry status
717
Enrollment target

NCT01383941: Completed study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

NCT01383941 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 717 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01383941 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

COMPLETED
Registry status
717 participants
Enrollment target

Study Summary

This is an epidemiologic, multi-center, cross-sectional study to define the phenotypic characteristics of Difficult-to-Treat asthma, among children between the ages of 6 to 17 years, receiving one year of guidelines-based therapy for asthma and rhinitis/rhinosinusitis.

Primary Outcome

This study is not a clinical trial with a single disease outcome or endpoint. The objective is to determine distinct characteristics that will discriminate Difficult-to-Treat from Easy-to-Treat asthmatic children in a employing multiple domains. Statistical procedures will be used to assess the relative strength of multiple relationships among many variables simultaneously.

Interventions

  • DRUG Guidelines-based asthma and rhinitis/rhinosinusitis therapy

Trial Details

FieldValue
Enrollment Target 717 participants
Start Date 2011-08
Est. Completion 2014-09

What the finished NCT01383941 record still lists

NCT01383941 is an observational study that tracks outcomes without assigning an intervention. The registered 717 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Guidelines-based asthma and rhinitis/rhinosinusitis therapy is the first listed.

NCT01383941 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01383941 about?

NCT01383941 is a clinical study titled "Asthma Phenotypes in the Inner City". This is an epidemiologic, multi-center, cross-sectional study to define the phenotypic characteristics of Difficult-to-Treat asthma, among children between the ages of 6 to 17 years, receiving one year of guidelines-based therapy for asthma and rhinitis/rhinosinusitis.

What is the current status of trial NCT01383941?

This trial is currently completed. The enrollment target is 717 participants. The study started on 2011-08. Estimated completion is 2014-09.

What interventions are being tested in trial NCT01383941?

The interventions under investigation include: Guidelines-based asthma and rhinitis/rhinosinusitis therapy (DRUG).

Who is sponsoring clinical trial NCT01383941?

This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04680000 · 716 participants · NA

    Chronic Pain Management In Primary Care Using Behavioral Health Consultants

  • NCT04916327 · 720 participants · NA

    Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 1

  • NCT05047224 · 720 participants · NA

    Addressing Disparities in Autism Spectrum Disorder Diagnosis Using a Direct-to-home Telemedicine Tool

  • NCT05309395 · 720 participants · Phase 3

    Food Prescriptions to Promote Affordable Diets

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01383941, the US trial registry maintained by the National Library of Medicine. NCT01383941 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.